NO923546L - Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde - Google Patents

Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde

Info

Publication number
NO923546L
NO923546L NO92923546A NO923546A NO923546L NO 923546 L NO923546 L NO 923546L NO 92923546 A NO92923546 A NO 92923546A NO 923546 A NO923546 A NO 923546A NO 923546 L NO923546 L NO 923546L
Authority
NO
Norway
Prior art keywords
prostaglandin
f3alfa
hypotensive agent
ocular hypotensive
reducing
Prior art date
Application number
NO92923546A
Other languages
English (en)
Other versions
NO923546D0 (no
Inventor
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/491,546 external-priority patent/US5011856A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO923546D0 publication Critical patent/NO923546D0/no
Publication of NO923546L publication Critical patent/NO923546L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører et middel for å redusere eller opprettholde intraokulart trykk, og nærmere bestemt en frem- gangsmåte og blanding for redusering eller opprettholdelse av intraokulart trykk som medfører administrering av en blanding inneholdende prostaglandin F, i en farmasøytisk akseptabel bærer.
NO92923546A 1990-03-12 1992-09-11 Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde NO923546L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/491,546 US5011856A (en) 1990-03-12 1990-03-12 Use of prostaglandin F3 α as an ocular hypotensive agent
PCT/US1991/000988 WO1991013620A1 (en) 1990-03-12 1991-02-12 USE OF PROSTAGLANDIN F3α AS AN OCULAR HYPOTENSIVE AGENT

Publications (2)

Publication Number Publication Date
NO923546D0 NO923546D0 (no) 1992-09-11
NO923546L true NO923546L (no) 1992-09-11

Family

ID=26782950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923546A NO923546L (no) 1990-03-12 1992-09-11 Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde

Country Status (2)

Country Link
AU (1) AU644642B2 (no)
NO (1) NO923546L (no)

Also Published As

Publication number Publication date
NO923546D0 (no) 1992-09-11
AU7455091A (en) 1991-10-10
AU644642B2 (en) 1993-12-16

Similar Documents

Publication Publication Date Title
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
DK0527801T3 (da) Thiophensulfonamider, der er anvendelige som carboanhydraseinhibitorer
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
NO20091159L (no) Hoyselektive reopptaksinhibitorer for norepinefrin
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
HK1007102A1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ES8609325A1 (es) Un procedimiento para preparar derivados de guanina
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
ATE130603T1 (de) Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate.
NO980058L (no) Opthalmiske preparater
NO923546L (no) Anvendelse av prostaglandin f3alfa som et okulart hypotensivt midde
NO923642L (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
KR850008664A (ko) 4-아미노-n-(1-페닐에틸)벤즈아미드의(s)-및(r)-에난티오머의 제조방법
DE69119900D1 (de) Verwendung von Prostaglandin F3alpha als okulares Hypotensivum
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
EP0122178A3 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
WO1992010473A3 (en) 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
MX9202807A (es) Conposiciones y metodos para tratamiento de glaucoma por la administracion topica de t-butilamino-3(4-morfolin-1,2,5-tiadiazol-3-iloxi-2-propanol hidrogeno maleato.
ES2116522T3 (es) Compuestos citotoxicos.
EP1300151A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU625096C (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension